Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager
Notified -
Globe Newswire2-09-2025, 17:00
VCI Global Completes Sagtec Global Limited’s Nasdaq IPO, Earning US$5.7 Million in Advisory Revenue 7-03-2025, 23:22